QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-buy-on-labcorp-hldgs-raises-price-target-to-325

UBS analyst Kevin Caliendo maintains Labcorp Hldgs (NYSE:LH) with a Buy and raises the price target from $305 to $325.

 mizuho-maintains-outperform-on-labcorp-hldgs-raises-price-target-to-320

Mizuho analyst Ann Hynes maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price target from $285 to $320.

 evercore-isi-group-maintains-outperform-on-labcorp-hldgs-raises-price-target-to-305

Evercore ISI Group analyst Elizabeth Anderson maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price targe...

 labcorp-teams-up-with-roche-to-bring-digital-pathology-scanners-to-us-labs-adopts-new-digital-imaging-tech-to-improve-cancer-and-disease-diagnoses

Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today a collaboration with Ro...

 labcorp-announced-the-availability-of-lumipulse-ptau-217beta-amyloid-42-ratio-first-blood-based-in-vitro-diagnostic-test-cleared-by-fda-for-diagnosis-of-alzheimers-disease

The test offers results that are comparable to existing methods that support a diagnosis of Alzheimer's disease – cerebrosp...

 labcorp-secures-ivdr-ce-marking-for-first-of-its-kind-in-vitro-diagnostic-test-for-solid-tumors-in-the-eu

First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for pa...

 truist-securities-maintains-buy-on-labcorp-hldgs-raises-price-target-to-310

Truist Securities analyst David Macdonald maintains Labcorp Hldgs (NYSE:LH) with a Buy and raises the price target from $290...

 ubs-maintains-buy-on-labcorp-hldgs-raises-price-target-to-305

UBS analyst Kevin Caliendo maintains Labcorp Hldgs (NYSE:LH) with a Buy and raises the price target from $282 to $305.

 evercore-isi-group-maintains-outperform-on-labcorp-hldgs-raises-price-target-to-300

Evercore ISI Group analyst Elizabeth Anderson maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price targe...

 morgan-stanley-maintains-overweight-on-labcorp-hldgs-raises-price-target-to-306

Morgan Stanley analyst Ricky Goldwasser maintains Labcorp Hldgs (NYSE:LH) with a Overweight and raises the price target from...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION